- In April 2023, Thermo Fisher Scientific Inc. (U.S.) launched the Orbitrap Astral mass spectrometer, a high-resolution system designed to advance proteomics and translational research. The new instrument enhances sensitivity and scan speed, enabling deeper insights into complex biological samples. This development reinforces Thermo Fisher’s leadership in supporting pharmaceutical and clinical researchers with next-generation analytical tools
- In March 2023, SCIEX (Canada), a global leader in mass spectrometry, introduced the Zeno SWATH DIA method for their ZenoTOF 7600 system, enhancing sensitivity and data quality in proteomics workflows. This advancement demonstrates SCIEX’s commitment to advancing data-independent acquisition (DIA) technologies and expanding capabilities for academic and clinical research users across North America
- In February 2023, Agilent Technologies Inc. (U.S.) announced the expansion of its MassHunter software suite with enhanced machine learning algorithms, enabling improved compound identification and faster data processing. The upgraded platform supports laboratories engaged in environmental testing, pharmaceutical quality control, and toxicology, reinforcing Agilent’s focus on user-friendly, AI-driven solutions in mass spectrometry
- In January 2023, Bruker Corporation (U.S.) unveiled enhancements to its timsTOF HT mass spectrometry platform, aimed at accelerating spatial proteomics and single-cell analysis. These innovations were presented at the US HUPO Conference and reflect Bruker’s commitment to high-throughput, high-resolution systems for cutting-edge life science applications
- In January 2023, PerkinElmer Inc. (U.S.) introduced new mass spectrometry-based screening solutions for food safety and environmental contamination detection. Targeting emerging regulatory needs across North America, these advancements highlight PerkinElmer’s role in supporting public health and compliance through innovative analytical instruments
